Liver cancer, Secondary cancers
Open
Phase 3
This trial is comparing 2 new combinations of treatment with for liver cancer that has spread.
It is for people who:
have a type of liver cancer called hepatocellular carcinoma
are having their first treatment for
can’t have treatment with the aim to cure
can’t have to the liver
You pronounce rilvegostomig as ril–veh–gost-oh-mig. You pronounce tremelimumab as treh-meh-lim-you-mab.
Recruitment start: 24 April 2026
Recruitment end: 31 January 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Pinato
AstraZeneca
Last reviewed: 28 Jul 2026
CRUK internal database number: 20164
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
